Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Aligos Therapeutics
What AI says about Aligos Therapeutics
Aligos Therapeutics leverages its expertise in medicinal chemistry and biology to create advanced therapies targeting liver and viral diseases. The company aims to address significant unmet medical needs with its differentiated pipeline of best-in-class treatments.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Not in this profile yet:
Products & Services
Pevifoscorvir sodium
An oral small molecule capsid assembly modulator (CAM-E) under development for chronic hepatitis B virus infection.
ALG-055009
An oral small molecule thyroid hormone receptor beta (THR-β) agonist under development for metabolic dysfunction-associated steatohepatitis (MASH).
Common Questions
What diseases does Aligos Therapeutics focus on?
Aligos Therapeutics focuses on liver and viral diseases, specifically chronic hepatitis B virus infection and metabolic dysfunction-associated steatohepatitis.
What is Pevifoscorvir sodium?
Pevifoscorvir sodium is an oral small molecule capsid assembly modulator under development for treating chronic hepatitis B virus infection.
What is ALG-055009?
ALG-055009 is an oral small molecule thyroid hormone receptor beta agonist being developed for metabolic dysfunction-associated steatohepatitis.